Viewpoint
Paradoxical Enhancement of Cancer Immunotherapy With JAK Inhibitors
Jonathan J. Park, MD, PhD; Jennifer N. Choi, MD
Editorial
Is Wide Local Excision After Primary Excision of Melanoma In Situ Unnecessary?
Katy J. L. Bell, PhD; H. Peter Soyer, MD; Peter M. Ferguson, PhD
Original Investigation
Local Recurrence and Survival in Patients With Melanoma In Situ
Clio Dessinioti, MD; Aggeliki Befon, MD; Mihaella Plaka, MD; et al.
Interleukin-17 Inhibitors and Early Major Adverse Cardiovascular Events
Maxime Raby, MD; Frederic Balusson, MS; Emmanuel Oger, MD, PhD; et al.
Images in Dermatology
Hypertrophic Lichen Planus
Ruimiao Wu, MD; Yu Hu, MD
Earn CME credit
Research Letter
High-Throughput Sequencing and Estimated Relapse Risk in Patients With Sézary Syndrome
Jeffrey D. Weiner, AB; David M. Weiner, MD; Bernice Benoit, BS; et al.
|